|
|
World Heart Corporation - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for World Heart Corporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
World Heart Corporation. The Group's principal activity is to develop artificial heart technologies. The Group is focused on two technologies: Novacor LVAS and the HeartSaver Ventricular Assist Device (HeartSaver). Novacor technology is currently in commercial production and the HeartSaver technology is currently under development. This technology is being developed from licensed artificial heart and related technologies developed by the Cardiovascular Devices Division (CVD) of the Ottawa Heart Institute Research Corporation. The Group operates in Canada and the United States.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|